{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:44:55Z","timestamp":1789771495729,"version":"4.0.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"Supplement_5","license":[{"start":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"New York State Department of Health AIDS Institute","award":["30567GG"],"award-info":[{"award-number":["30567GG"]}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["T32MH019139-30"],"award-info":[{"award-number":["T32MH019139-30"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV) is highly effective. However, people who inject drugs face significant barriers to DAA access.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We describe a program that colocates HCV management within a syringe service program in New York City. We performed a retrospective chart review of all patients with confirmed HCV viremia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>From 2015 to 2018, 102 patients with viremia completed intake. Fifty-eight patients started DAAs. Nine patients discontinued treatment or were lost to follow-up before completion; 1 is continuing DAA treatment. Of 48 patients who completed therapy, sustained virologic response (SVR) was achieved in 43 (89.6%). Age and established mental health treatment at intake were associated with SVR. Regular cocaine use was negatively associated with SVR in univariate analysis, but this association was not significant after adjustment for age. Of 30 patients completing DAA therapy with active illicit opioid use at intake, 14 (46.4%) engaged in opioid use disorder (OUD) treatment during therapy, and 9 remained in OUD treatment after completion of DAA treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Loss to follow-up is a challenge for people who inject drugs, but among those who completed treatment, SVR was achieved at a high rate. Mental health treatment may facilitate HCV cure. Conversely, HCV therapy may facilitate engagement in OUD treatment and other services.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiaa142","type":"journal-article","created":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T04:38:32Z","timestamp":1585197512000},"page":"S392-S400","source":"Crossref","is-referenced-by-count":24,"title":["Psychosocial Factors and the Care Cascade for Hepatitis C Treatment Colocated at a Syringe Service Program"],"prefix":"10.1093","volume":"222","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7423-2187","authenticated-orcid":false,"given":"Daniel","family":"Winetsky","sequence":"first","affiliation":[{"name":"Comprehensive Health Program, New York Presbyterian Hospital, New York, USA"},{"name":"Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, USA"},{"name":"HIV Center for Clinical and Behavioral Studies at Columbia University and New York State Psychiatric Institute, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Burack","sequence":"additional","affiliation":[{"name":"Department of Medicine, Columbia University Irving Medical Center, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantelis","family":"Antoniou","sequence":"additional","affiliation":[{"name":"Comprehensive Health Program, New York Presbyterian Hospital, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill","family":"Garcia","sequence":"additional","affiliation":[{"name":"Washington Heights Corner Project, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gordon","sequence":"additional","affiliation":[{"name":"Comprehensive Health Program, New York Presbyterian Hospital, New York, USA"},{"name":"Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Scherer","sequence":"additional","affiliation":[{"name":"Comprehensive Health Program, New York Presbyterian Hospital, New York, USA"},{"name":"Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,2]]},"reference":[{"key":"2020101904444867800_CIT0001","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/hep.27978","article-title":"Toward a more accurate estimate of the prevalence of hepatitis C in the United States","volume":"62","author":"Edlin","year":"2015","journal-title":"Hepatology"},{"key":"2020101904444867800_CIT0002","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/s41598-017-01862-6","article-title":"Impact of hepatitis C treatment as prevention for people who inject drugs is sensitive to contact network structure","volume":"7","author":"Metzig","year":"2017","journal-title":"Sci Rep"},{"key":"2020101904444867800_CIT0003","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s41124-018-0036-5","article-title":"Achieving a hepatitis C cure: a qualitative exploration of the experiences and meanings of achieving a hepatitis C cure using the direct acting antivirals in Australia","volume":"3","author":"Richmond","year":"2018","journal-title":"Hepatol Med Policy"},{"key":"2020101904444867800_CIT0004","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.socscimed.2008.10.011","article-title":"A meta-analysis of the hepatitis C virus distribution in diverse racial\/ethnic drug injector groups","volume":"68","author":"Lelutiu-Weinberger","year":"2009","journal-title":"Soc Sci Med"},{"key":"2020101904444867800_CIT0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.drugalcdep.2018.07.034","article-title":"Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000\u20132017: protective effects of non-injecting drug use","volume":"192","author":"Des Jarlais","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"2020101904444867800_CIT0006","author":"Centers for Disease Control and Prevention (CDC)"},{"key":"2020101904444867800_CIT0007","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2105\/AJPH.2017.304132","article-title":"Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014","volume":"108","author":"Zibbell","year":"2018","journal-title":"Am J Public Health"},{"key":"2020101904444867800_CIT0008","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/10826084.2018.1485699","article-title":"Hepatitis C testing, status and treatment among marginalized people who use drugs in an inner city setting: an observational cohort study","volume":"54","author":"Boucher","year":"2019","journal-title":"Subst Use Misuse"},{"key":"2020101904444867800_CIT0009","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.drugalcdep.2019.02.008","article-title":"Treatment cascade for hepatitis C virus in young adult people who inject drugs in San Francisco: low number treated","volume":"198","author":"Morris","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"2020101904444867800_CIT0010","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/liv.14043","article-title":"Disparities in uptake of direct-acting antiviral therapy for hepatitis C among people who inject drugs in a Canadian setting","volume":"39","author":"Soc\u00edas","year":"2019","journal-title":"Liver Int"},{"key":"2020101904444867800_CIT0011","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.drugalcdep.2018.11.026","article-title":"Hepatitis C continuum of care and utilization of healthcare and harm reduction services among persons who inject drugs in Seattle","volume":"195","author":"Tsui","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"2020101904444867800_CIT0012","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.drugpo.2019.01.012","article-title":"Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs","volume":"66","author":"Day","year":"2019","journal-title":"Int J Drug Policy"},{"key":"2020101904444867800_CIT0013","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.drugpo.2019.05.023","article-title":"Integrated models of care for people who inject drugs and live with hepatitis C virus: a systematic review","volume":"72","author":"Soc\u00edas","year":"2019","journal-title":"Int J Drug Policy"},{"key":"2020101904444867800_CIT0014","first-page":"69","article-title":"The Consensus Hepatitis C Cascade of Care: standardized reporting to monitor progress toward elimination","author":"Safreed-Harmon","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020101904444867800_CIT0015","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/jamainternmed.2013.6841","article-title":"Differences in human immunodeficiency virus care and treatment among subpopulations in the United States","volume":"173","author":"Hall","year":"2013","journal-title":"JAMA Intern Med"},{"key":"2020101904444867800_CIT0016","doi-asserted-by":"crossref","first-page":"77","DOI":"10.15585\/mmwr.mm6504a2","article-title":"Disparities in consistent retention in HIV Care\u201411 states and the District of Columbia, 2011\u20132013","volume":"65","author":"Dasgupta","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2020101904444867800_CIT0017","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/apc.2016.0197","article-title":"Retention in HIV care and viral suppression: individual- and neighborhood-level predictors of racial\/ethnic differences, Florida, 2015","volume":"31","author":"Sheehan","year":"2017","journal-title":"AIDS Patient Care STDs"},{"key":"2020101904444867800_CIT0018","first-page":"1113","article-title":"Vital signs: HIV diagnosis, care, and treatment among persons living with HIV\u2014United States, 2011","volume":"63","author":"Bradley","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2020101904444867800_CIT0019","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11904-015-0285-5","article-title":"The impact of alcohol use and related disorders on the HIV continuum of care: a systematic review: alcohol and the HIV continuum of care","volume":"12","author":"Vagenas","year":"2015","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2020101904444867800_CIT0020","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1097\/QAD.0000000000001183","article-title":"A longitudinal, HIV care continuum: 10-year restricted mean time in each care continuum stage after enrollment in care, by history of IDU","volume":"30","author":"Lesko","year":"2016","journal-title":"AIDS"},{"key":"2020101904444867800_CIT0021","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/j.1360-0443.2008.02323.x","article-title":"The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study","volume":"103","author":"Roux","year":"2008","journal-title":"Addiction"},{"key":"2020101904444867800_CIT0022","article-title":"Degree of housing instability shows independent \u201cdose-response\u201d with virologic suppression rates among people living with human immunodeficiency virus [published correction appears in Open Forum Infect Dis 2018; 5:ofy271]","volume":"5","author":"Clemenzi-Allen","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2020101904444867800_CIT0023","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/cid\/civ941","article-title":"Continuous retention and viral suppression provide further insights into the HIV care continuum compared to the cross-sectional HIV care cascade","volume":"62","author":"Colasanti","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2020101904444867800_CIT0024","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.2105\/AJPH.2015.302635","article-title":"The HIV care cascade before, during, and after incarceration: a systematic review and data synthesis","volume":"105","author":"Iroh","year":"2015","journal-title":"Am J Public Health"},{"key":"2020101904444867800_CIT0025","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy202","article-title":"Hepatitis C within a single health system: progression along the cascade to cure is higher for those with substance misuse when linked to a clinic with embedded support services","volume":"5","author":"Sherbuk","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2020101904444867800_CIT0026","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.drugpo.2019.03.017","article-title":"Hepatitis C treatment outcomes among homeless-experienced individuals at a community health centre in Boston","volume":"72","author":"Beiser","year":"2019","journal-title":"Int J Drug Policy"},{"key":"2020101904444867800_CIT0027","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.drugalcdep.2015.06.007","article-title":"\u201cHepatitis C treatment turned me around\u201d: psychological and behavioral transformation related to hepatitis C treatment","volume":"153","author":"Batchelder","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"2020101904444867800_CIT0028","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12954-019-0314-6","article-title":"HCV treatment access among Latinxs who inject drugs: qualitative findings from Boston, Massachusetts, 2016","volume":"16","author":"Mittal","year":"2019","journal-title":"Harm Reduct J"},{"key":"2020101904444867800_CIT0029","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/apt.13269","article-title":"The patient\u2019s journey with chronic hepatitis C from interferon plus ribavirin to interferon- and ribavirin-free regimens: a study of health-related quality of life","volume":"42","author":"Younossi","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"2020101904444867800_CIT0030","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1360-0443.2011.03608.x","article-title":"Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users","volume":"107","author":"Roux","year":"2012","journal-title":"Addiction"},{"key":"2020101904444867800_CIT0031","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.drugpo.2019.05.011","article-title":"Impact of hepatitis C treatment on behavioural change in relation to drug use in people who inject drugs: a systematic review","volume":"72","author":"Caven","year":"2019","journal-title":"Int J Drug Policy"},{"key":"2020101904444867800_CIT0032","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1093\/cid\/ciz714","article-title":"The Consensus Hepatitis C Cascade of Care: standardized reporting to monitor progress toward elimination","volume":"69","author":"Safreed-Harmon","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020101904444867800_CIT0033","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy048","article-title":"Hepatitis C treatment outcomes for people who inject drugs treated in an accessible care program located at a syringe service program","volume":"5","author":"Eckhardt","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2020101904444867800_CIT0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugpo.2019.02.009","article-title":"Evaluation of contingency management as a strategy to improve HCV linkage to care and treatment in persons attending needle and syringe programs: a pilot study","volume":"69","author":"Norton","year":"2019","journal-title":"Int J Drug Policy"},{"key":"2020101904444867800_CIT0035","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/j.cgh.2015.02.022","article-title":"Integrated care increases treatment and improves outcomes of patients with chronic hepatitis C virus infection and psychiatric illness or substance abuse","volume":"13","author":"Ho","year":"2015","journal-title":"Clinical Gastroenterol Hepatol"},{"key":"2020101904444867800_CIT0036","doi-asserted-by":"crossref","first-page":"e1002715","DOI":"10.1371\/journal.pmed.1002715","article-title":"Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: a systematic review and network meta-analysis","volume":"15","author":"De Crescenzo","year":"2018","journal-title":"PLoS Med"},{"key":"2020101904444867800_CIT0037","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1037\/0033-295X.84.2.191","article-title":"Self-efficacy: toward a unifying theory of behavioral change","volume":"84","author":"Bandura","year":"1977","journal-title":"Psychol Rev"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/222\/Supplement_5\/S392\/33940750\/jiaa142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/222\/Supplement_5\/S392\/33940750\/jiaa142.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T09:47:59Z","timestamp":1603100879000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/222\/Supplement_5\/S392\/5900590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,2]]},"references-count":37,"journal-issue":{"issue":"Supplement_5","published-online":{"date-parts":[[2020,9,2]]},"published-print":{"date-parts":[[2020,9,2]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaa142","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10,1]]},"published":{"date-parts":[[2020,9,2]]}}}